Cite
HARVARD Citation
Habibi, J. et al. (2017). Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes. Cardiovascular diabetology. 16 (1), pp. 1-15. [Online].